• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.27% Nasdaq Up 0.04%

    Regulus Therapeutics Inc. (RGLS)

    -NasdaqGM
    12.78 Up 0.03(0.24%) 12:08PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:12.75
    Open:12.74
    Bid:12.68 x 100
    Ask:12.71 x 300
    1y Target Est:31.80
    Beta:1.34
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:12.66 - 13.01
    52wk Range:6.08 - 25.60
    Volume:53,231
    Avg Vol (3m):586,273
    Market Cap:652.00M
    P/E (ttm):N/A
    EPS (ttm):-1.27
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RGLS

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):63.22
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.12
    Quarterly EPS Est (Jun-15) :-0.29
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):-0.29

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of drugs that target microRNAs for the treatment of various diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback